Standard
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. / Jarrin, Inma; Pantazis, Nikos; Gill, M John; Geskus, Ronald; Perez-Hoyos, Santiago; Meyer, Laurence; Prins, Maria; Touloumi, Giota; Johnson, Anne; Hamouda, Osamah; de Olalla, Patricia García; Porter, Kholoud; del Amo, Julia; CASCADE Collaboration in EuroCoord ; Kirk, Ole.
I:
Clinical Infectious Diseases, Bind 54, Nr. 1, 2012, s. 111-8.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Jarrin, I, Pantazis, N, Gill, MJ, Geskus, R, Perez-Hoyos, S, Meyer, L, Prins, M, Touloumi, G, Johnson, A, Hamouda, O, de Olalla, PG, Porter, K, del Amo, J, CASCADE Collaboration in EuroCoord
& Kirk, O 2012, '
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia',
Clinical Infectious Diseases, bind 54, nr. 1, s. 111-8.
https://doi.org/10.1093/cid/cir814APA
Jarrin, I., Pantazis, N., Gill, M. J., Geskus, R., Perez-Hoyos, S., Meyer, L., Prins, M., Touloumi, G., Johnson, A., Hamouda, O., de Olalla, P. G., Porter, K., del Amo, J., CASCADE Collaboration in EuroCoord
, & Kirk, O. (2012).
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.
Clinical Infectious Diseases,
54(1), 111-8.
https://doi.org/10.1093/cid/cir814Vancouver
Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L o.a.
Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.
Clinical Infectious Diseases. 2012;54(1):111-8.
https://doi.org/10.1093/cid/cir814Author
Jarrin, Inma ; Pantazis, Nikos ; Gill, M John ; Geskus, Ronald ; Perez-Hoyos, Santiago ; Meyer, Laurence ; Prins, Maria ; Touloumi, Giota ; Johnson, Anne ; Hamouda, Osamah ; de Olalla, Patricia García ; Porter, Kholoud ; del Amo, Julia ; CASCADE Collaboration in EuroCoord ; Kirk, Ole. / Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. I: Clinical Infectious Diseases. 2012 ; Bind 54, Nr. 1. s. 111-8.
Bibtex
@article{116678a38e8740c5bd779b11ec3b8f01,
title = "Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia",
abstract = "We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).",
author = "Inma Jarrin and Nikos Pantazis and Gill, {M John} and Ronald Geskus and Santiago Perez-Hoyos and Laurence Meyer and Maria Prins and Giota Touloumi and Anne Johnson and Osamah Hamouda and {de Olalla}, {Patricia Garc{\'i}a} and Kholoud Porter and {del Amo}, Julia and Ole Kirk and Ole Kirk",
year = "2012",
doi = "10.1093/cid/cir814",
language = "English",
volume = "54",
pages = "111--8",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "1",
}
RIS
TY - JOUR
T1 - Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia
AU - Jarrin, Inma
AU - Pantazis, Nikos
AU - Gill, M John
AU - Geskus, Ronald
AU - Perez-Hoyos, Santiago
AU - Meyer, Laurence
AU - Prins, Maria
AU - Touloumi, Giota
AU - Johnson, Anne
AU - Hamouda, Osamah
AU - de Olalla, Patricia García
AU - Porter, Kholoud
AU - del Amo, Julia
AU - CASCADE Collaboration in EuroCoord
AU - Kirk, Ole
PY - 2012
Y1 - 2012
N2 - We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).
AB - We examined differences by geographical origin (GO) in time from HIV seroconversion (SC) to AIDS, death, and initiation of antiretroviral therapy (cART).
U2 - 10.1093/cid/cir814
DO - 10.1093/cid/cir814
M3 - Journal article
C2 - 22109944
VL - 54
SP - 111
EP - 118
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
SN - 1058-4838
IS - 1
ER -
